Alzheimer's disease: A need for personalized therapeutic approaches

Drug Dev Res. 2020 Apr;81(2):141-143. doi: 10.1002/ddr.21652. Epub 2020 Mar 3.

Author

Dan Frenkel^{1

2}

Affiliations

¹ Department of Neurobiology, George S. Wise Faculty of Life Sciences, The School of Neurobiology, Biochemistry and Biophysics, Tel Aviv, Israel.
² Sagol School of Neuroscience, Tel Aviv University, Tel Aviv, Israel.

PMID: 32125005
DOI: 10.1002/ddr.21652

No abstract available

Publication types

Editorial
Introductory Journal Article

MeSH terms

Aged, 80 and over
Alzheimer Disease / drug therapy*
Alzheimer Disease / epidemiology
Alzheimer Disease / immunology
Animals
Antipsychotic Agents / pharmacology*
Antipsychotic Agents / therapeutic use
Drug Development
Gene Regulatory Networks* / drug effects
Global Health
Humans
Lipid Metabolism
Molecular Targeted Therapy
Precision Medicine

Substances

Antipsychotic Agents